Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 420 All time
- Disclosed funding
- $108.3B 379 disclosed amounts
- Median round
- $120M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Q QuadricCompany profile Quadric is a licensor of fully programmable general-purpose AI inference processor IP Quadric is a licensor of fully programmable general-purpose AI inference processor IP | $16M | Series C+ | Hardware | United States | Investors | |
| H HelsingCompany profile Develops AI software and autonomous systems for military and national security applications Develops AI software and autonomous systems for military and national security applications | $1.8B | Series ESeries C+ | Defense tech | Germany | Investors | |
| DF Drug FarmCompany profile Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases | $55M | Series DSeries C+ | Biotech | China | Investors | |
| HH Grows USDA-certified organic greens using robotics and machine learning | $30M | Series CSeries C+ | Agritech | United States | Investors | |
| S SambaNovaCompany profile Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives | $1B | Series FSeries C+ | AI | United States | Investors | |
| AT Allotera TherapeuticsCompany profile Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. | $35M | Series C extension and venture debtSeries C+ | Biotech | United States | Investors | |
| LC Leo Cancer CareCompany profile Develops cancer-care systems for treating patients in an upright position. Develops cancer-care systems for treating patients in an upright position. | $65M | Series DSeries C+ | Healthtech | United States | Investors | |
| NA Norm AiCompany profile Builds agentic law for high-stakes work by bringing AI engineers and attorneys together to embed law into AI agents Builds agentic law for high-stakes work by bringing AI engineers and attorneys together to embed law into AI agents | $120M | Series CSeries C+ | Enterprise software | United States | Investors | |
| B BIZAYCompany profile Provides digital platform for customized marketing materials, packaging, and promotional products Provides digital platform for customized marketing materials, packaging, and promotional products | $55M | Series DSeries C+ | Ecommerce | Portugal | Investors | |
| EM Provides institutional digital asset infrastructure and trading venue | $76M | Series CSeries C+ | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
Labelbox, Valon, Devoted Health
35rounds3led - 2Sequoia Capital
Blacksmith, Abby Care, Instinct
31rounds2led - 3Lightspeed
Enveda, Snorkel AI, Profound
28rounds3led - 4General Catalyst
Legora, Modal Labs, Varda
27rounds0led - 5Y Combinator (YC)
Blacksmith, Jeeves, Hubble Network
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.